Pharmacist-Led Education to Improve Neutropenic Precautions in Cancer Patients

The goal of this clinical trial is to test whether pharmacist-led education can improve knowledge and adherence to neutropenic precautions and reduce infection rates in adult cancer patients receiving high-risk chemotherapy. The main questions it aims to answer are: * Does pharmacist-led education improve patient knowledge of neutropenic fever prevention? * Does it increase adherence to precautionary behaviors? * Does it reduce the incidence of febrile neutropenia? Researchers will compare two groups: one receiving standard care and the other receiving additional education by a clinical pharmacist, to assess the impact on patient behavior and infection outcomes. Participants will: * Receive either standard care or a structured educational intervention that includes written materials, a counseling session, and an instructional video on neutropenic precautions. * Complete knowledge and adherence surveys before and after the intervention. * Be followed for 2-6 months to monitor adherence, infection rates, and treatment outcomes.

NCT Number	NCT07690956
Lead Sponsor	Jordan University of Science and Technology
Conditions	Febrile Neutropenia
Enrollment	300 participants
Start Date	2025-07-13
Primary Completion	2026-07-31 (estimated)
Study Completion	2026-08-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-08